131 related articles for article (PubMed ID: 12610740)
41. Early pharmacokinetic of ropivacaine without epinephrine after injection into the psoas compartment.
Hübler M; Planitz MC; Vicent O
Br J Anaesth; 2015 Jan; 114(1):130-5. PubMed ID: 25303987
[TBL] [Abstract][Full Text] [Related]
42. The pharmacokinetics of ropivacaine after intraperitoneal administration: instillation versus nebulization.
Betton D; Greib N; Schlotterbeck H; Joshi GP; Ubeaud-Sequier G; Diemunsch P
Anesth Analg; 2010 Nov; 111(5):1140-5. PubMed ID: 20841409
[TBL] [Abstract][Full Text] [Related]
43. Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia.
Raaska K; Neuvonen PJ
Eur J Clin Pharmacol; 2000 Nov; 56(8):585-9. PubMed ID: 11151749
[TBL] [Abstract][Full Text] [Related]
44. Postoperative course of plasma protein binding of lignocaine, ropivacaine and bupivacaine in sheep.
Rutten AJ; Mather LE; Plummer JL; Henning EC
J Pharm Pharmacol; 1992 Apr; 44(4):355-8. PubMed ID: 1355550
[TBL] [Abstract][Full Text] [Related]
45. Lack of metabolic racemisation of ropivacaine, determined by liquid chromatography using a chiral AGP column.
Arvidsson T; Bruce HF; Halldin MM
Chirality; 1995; 7(4):272-7. PubMed ID: 7640170
[TBL] [Abstract][Full Text] [Related]
46. Effect of Intralipid® on the Dose of Ropivacaine or Levobupivacaine Tolerated by Volunteers: A Clinical and Pharmacokinetic Study.
Dureau P; Charbit B; Nicolas N; Benhamou D; Mazoit JX
Anesthesiology; 2016 Sep; 125(3):474-83. PubMed ID: 27404223
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics of ropivacaine in nonpregnant and pregnant ewes.
Santos AC; Pedersen H; Sallusto JA; Johnson HV; Morishima HO; Finster M; Arthur GR; Covino BG
Anesth Analg; 1990 Mar; 70(3):262-6. PubMed ID: 2305977
[TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
[TBL] [Abstract][Full Text] [Related]
49. Involvement of alpha1-acid glycoprotein in inter-individual variation of disposition kinetics of ropivacaine following epidural infusion in off-pump coronary artery bypass grafting.
Yokogawa K; Shimomura S; Ishizaki J; Shimada T; Fukuwa C; Kawada M; Tsubokawa T; Yamamoto K; Miyamoto K
J Pharm Pharmacol; 2007 Jan; 59(1):67-73. PubMed ID: 17227622
[TBL] [Abstract][Full Text] [Related]
50. The effect of ciprofloxacin and clarithromycin on sildenafil oral bioavailability in human volunteers.
Hedaya MA; El-Afify DR; El-Maghraby GM
Biopharm Drug Dispos; 2006 Mar; 27(2):103-10. PubMed ID: 16372380
[TBL] [Abstract][Full Text] [Related]
51. Determination of free concentration of ropivacaine and bupivacaine in blood plasma by ultrafiltration and coupled-column liquid chromatography.
Arvidsson T; Eklund E
J Chromatogr B Biomed Appl; 1995 Jun; 668(1):91-8. PubMed ID: 7550986
[TBL] [Abstract][Full Text] [Related]
52. Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam--probes of CYP2C9, CYP1A2, and CYP3A4.
Lilja JJ; Backman JT; Neuvonen PJ
Clin Pharmacol Ther; 2007 Jun; 81(6):833-9. PubMed ID: 17392729
[TBL] [Abstract][Full Text] [Related]
53. No volume effect on retrograde colonic spread of rectally-administered ropivacaine gel.
Arlander E; Cederlund T; Måre K
Aliment Pharmacol Ther; 2003 Sep; 18(6):655-60. PubMed ID: 12969093
[TBL] [Abstract][Full Text] [Related]
54. The effect of a long term epidural infusion of ropivacaine on CYP2D6 activity.
Wink J; Veering BT; Kruit M; Burm AG; Huledal GA; Ekström GY; Stienstra R; van Kleef JW
Anesth Analg; 2008 Jan; 106(1):143-6, table of contents. PubMed ID: 18165569
[TBL] [Abstract][Full Text] [Related]
55. Ropivacaine in neonates and infants: a population pharmacokinetic evaluation following single caudal block.
Rapp HJ; Molnár V; Austin S; Krohn S; Gädeke V; Motsch J; Boos K; Williams DG; Gustafsson U; Huledal G; Larsson LE
Paediatr Anaesth; 2004 Sep; 14(9):724-32. PubMed ID: 15330953
[TBL] [Abstract][Full Text] [Related]
56. Metabolism and elimination of quinine in healthy volunteers.
Mirghani RA; Hellgren U; Bertilsson L; Gustafsson LL; Ericsson O
Eur J Clin Pharmacol; 2003 Sep; 59(5-6):423-7. PubMed ID: 12920491
[TBL] [Abstract][Full Text] [Related]
57. Plasma concentrations of ropivacaine given with or without epinephrine for brachial plexus block.
Hickey R; Blanchard J; Hoffman J; Sjovall J; Ramamurthy S
Can J Anaesth; 1990 Nov; 37(8):878-82. PubMed ID: 2253294
[TBL] [Abstract][Full Text] [Related]
58. Molecularly imprinted polymer in microextraction by packed sorbent for the simultaneous determination of local anesthetics: lidocaine, ropivacaine, mepivacaine and bupivacaine in plasma and urine samples.
Daryanavard SM; Jeppsson-Dadoun A; Andersson LI; Hashemi M; Colmsjö A; Abdel-Rehim M
Biomed Chromatogr; 2013 Nov; 27(11):1481-8. PubMed ID: 23832864
[TBL] [Abstract][Full Text] [Related]
59. Effects of ciprofloxacin on the stereoselective disposition of mexiletine in man.
Labbé L; Robitaille NM; Lefez C; Potvin D; Gilbert M; O'Hara G; Turgeon J
Ther Drug Monit; 2004 Oct; 26(5):492-8. PubMed ID: 15385831
[TBL] [Abstract][Full Text] [Related]
60. Ropivacaine gel in active distal ulcerative colitis and proctitis -- a pharmacokinetic and exploratory clinical study.
Arlander E; Ost A; Stahlberg D; Lofberg R
Aliment Pharmacol Ther; 1996 Feb; 10(1):73-81. PubMed ID: 8871446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
